A review of ADHD in India published this year in Frontiers in Psychiatry cites a study of 101 adults who went looking for help. Seventy-eight were men. Twenty-three were women.
ADHD is markedly under-diagnosed in India, and prevalence estimates from Indian studies range from 1.5% to 14.4% depending on where and how researchers looked, according to the review. It recommends recognizing the condition under the Rights of Persons with Disabilities Act, 2016, which does not currently list it.
The authors are Althaf Mahin, Bristow Ben Joseph, Fathimathul Sunaina, Fathimathu Rasana and Rajesh Raju of the Center for Integrative Omics Data Science at Yenepoya (Deemed to be University), Mangalore. Mahin and Raju are the corresponding authors. The paper is a narrative review drawing together Indian epidemiological studies, diagnostic practice, treatment access, and policy.
Prevalence estimates range tenfold across states
The review collects the following figures from Indian studies.
For global comparison, the authors cite prevalence of 7.6% in children aged 3 to 12 and 5.6% in adolescents aged 12 to 18 (Salari et al., 2023).
The authors state that the Indian estimates vary widely because of differences in study design, screening instruments and access to care.
Diagnosis concentrated in metropolitan centers
The review reports pervasive gaps in awareness, delayed identification and limited access to specialized interventions. Specialist services are concentrated in metropolitan centers, while rural areas and smaller urban areas have limited access.
In rural communities, the authors write, ADHD symptoms are often interpreted as indiscipline, poor upbringing or a lack of motivation, and some traditional beliefs attribute them to spiritual or moral causes. The review notes that culturally adapted assessment tools have been developed in India, including the INDT-ADHD associated with AIIMS, and that the ECHO-ADHD program aims to close service gaps through training and tele-mentoring.
Girls and women under-recognized
Boys in India are approximately twice as likely as girls to receive an ADHD diagnosis, according to the review. It attributes the gap in part to presentation: female symptoms tend to be internalizing, including low self-esteem, affective disturbance and inattention, rather than hyperactivity.
The authors cite a study of 101 treatment-seeking Indian adults with ADHD, of whom 78 were men and 23 were women. They name female ADHD as a priority research area.
Methylphenidate is the primary medication
Methylphenidate is the primary ADHD medication in India, the review states. Atomoxetine and clonidine are used where stimulants are contraindicated or poorly tolerated, or where anxiety or tic disorders are present.
Barriers to treatment include cost, regulatory requirements, shortages of specialists particularly in rural areas, adherence concerns, stigma, and limited awareness among caregivers and teachers. Behavioral therapy, parent training and school-based support are described as inconsistently available, while use of CBT is growing for adolescents and adults. Evidence for complementary approaches, including Ayurveda, yoga, and meditation, is described as limited.
Comorbidity and environmental factors
In clinical cases, the review reports externalizing disorders such as oppositional defiant disorder and conduct disorder in 20% to 50%, learning disorders in 20% to 40%, and anxiety and depression in substantial minorities.



